TL;DR: A 2026 qualitative analysis in PLOS One used 505 ME/CFS memorial entries to map how systemic neglect, clinical dismissal, social isolation, and personal burden appeared in accounts of illness and death. Key Findings 505 memorial entries: The analysis used the National CFIDS Foundation memorial list, downloaded in October 2024. 4 theme layers: Themes were …
TL;DR: A 2026 meta-analysis in Sleep and Breathing found that GLP-1 drugs, metabolic hormone medications involved in glucose, appetite, and weight regulation, were linked to fewer obstructive sleep apnea breathing events in adults with obesity. Key Findings Sleep apnea events fell: GLP-1 treatment reduced apnea-hypopnea index (AHI), a count of breathing interruptions per hour of …
TL;DR: A 2026 analysis in Journal of Korean Medical Science identified PIK3CG, PRKCD, and TRIM22 as glioblastoma gene markers linked to worse survival and stronger immune-activity signals in IDH-wildtype tumors. Key Findings 12,041-gene screen: Researchers screened tumor expression data to find genes tied to both poor prognosis and immune activation in grade IV glioma. 775 …
TL;DR: A pilot cohort study in JMIR Rehabilitation and Assistive Technologies found that online emotional training after facial palsy surgery improved facial movement, social well-being, and anxiety about as much as in-person therapy in 16 adults. Key Findings Population: The study followed 16 adults after triple innervation surgery for unilateral peripheral facial nerve palsy. Delivery: …
TL;DR: A 2026 randomized trial in Archives of Disease in Childhood: Fetal and Neonatal Edition found that extended caffeine therapy reduced intermittent hypoxia, brief repeated oxygen-desaturation episodes, in very preterm infants through 41 weeks postmenstrual age. Key Findings 160 infants randomized: The ICAF trial assigned 78 infants to placebo and 82 infants to extended caffeine …
TL;DR: A 2026 placebo-controlled study in Human Psychopharmacology: Clinical and Experimental found that ebselen did not meaningfully reduce motor impulsivity, reflection impulsivity, delay discounting, or emotion-recognition outcomes in 130 healthy adults. Key Findings 130 adults analyzed: The double-blind study compared 66 adults assigned to ebselen with 64 assigned to placebo. 1800 mg over 2 days: …
TL;DR: A 2026 review in Current Opinion in Psychiatry found that earlier clozapine use in schizophrenia, especially after early nonresponse or relapse, was linked to better relapse prevention and stronger response rates than repeated nonclozapine antipsychotic trials. Key Findings Relapse prevention improved: Switching to clozapine after first relapse was associated with a 34% lower subsequent …
TL;DR: A 2026 Phase I study in CNS Drugs found that a 400 mg powdered cannabidiol (CBD) formulation reached peak blood levels faster than oil-based Epidyolex, especially after a high-fat meal, while both products were generally well tolerated in healthy adults. Key Findings Four-way crossover trial: Researchers gave 32 healthy adults single 400 mg doses …
TL;DR: A 2026 study in Biochemistry and Biophysics Reports found that cannabinoid receptor 1 (CB1R) undergoes autophagy-linked degradation in mouse cortical neurons, but p62 deficiency did not make CB1R the main driver of obesity and low activity in p62 knockout mice. Key Findings CB1R accumulated up to 10-fold: Blocking autophagic flux with Bafilomycin A1 in …
TL;DR: A 2026 case study in Neurological Sciences described 2 Tourette syndrome patients who developed oculogyric crisis, a sustained upward eye-rolling dystonia, after aripiprazole was increased to 20-30 mg/day, with both cases resolving after dose reduction. Key Findings 2 Tourette cases: The report described 2 female patients, ages 16 and 22, treated with aripiprazole for …
